We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRTX
8551
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$22K ﹤0.01%
60
+7
+13% +$2.75K
EMAN
8552
DELISTED
eMagin Corporation
EMAN
$22K ﹤0.01%
+21,682
New +$28.2K
VIVE
8553
DELISTED
VIVEVE MED INC
VIVE
$22K ﹤0.01%
+21
New +$50.4K
MN
8554
DELISTED
MANNING & NAPIER, INC.
MN
$22K ﹤0.01%
+12,336
New +$25.6K
NBRV
8555
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$22K ﹤0.01%
61
-96
-61% -$51.6K
SMRT
8556
CALL
DELISTED
Stein Mart Inc
SMRT
$22K ﹤0.01%
20,500
-10,100
-33% -$17.4K
PIR
8557
DELISTED
Pier 1 Imports, Inc.
PIR
$22K ﹤0.01%
3,647
-20,747
-85% -$568K
SDLP
8558
PUT
DELISTED
SEADRILL PARTNERS LLC
SDLP
$22K ﹤0.01%
+1,260
New +$37K
ONCS
8559
DELISTED
OncoSec Medical Incorporated
ONCS
$22K ﹤0.01%
+155
New +$38.9K
CYTR
8560
CALL
DELISTED
CytRx Corp
CYTR
$22K ﹤0.01%
48,900
-15,000
-23% -$10.4K
PGLC
8561
CALL
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$22K ﹤0.01%
+20,500
New +$24.5K
AST
8562
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$22K ﹤0.01%
35,597
-33,120
-48% -$34.4K
ALTO icon
8563
CALL
Alto Ingredients
ALTO
$326M
$21K ﹤0.01%
24,200
-9,800
-29% -$16.2K
AVXL icon
8564
CALL
Anavex Life Sciences
AVXL
$294M
$21K ﹤0.01%
13,700
-2,400
-15% -$5.45K
DRRX
8565
DELISTED
DURECT Corp
DRRX
$21K ﹤0.01%
4,265
-3,024
-41% -$26.4K
DXF
8566
Eason Technology Ltd
DXF
$1.63M
$21K ﹤0.01%
+9
New +$39K
FTEK icon
8567
Fuel Tech
FTEK
$45.6M
$21K ﹤0.01%
+18,021
New +$22.7K
NDRA icon
8568
ENDRA Life Sciences
NDRA
$5.58M
0
NMM icon
8569
CALL
Navios Maritime Partners
NMM
$2.32B
$21K ﹤0.01%
1,640
-387
-19% -$7.93K
SLS icon
8570
SELLAS Life Sciences
SLS
$2.5B
$21K ﹤0.01%
+340
New +$26.3K
SMMT icon
8571
Summit Therapeutics
SMMT
$10.5B
$21K ﹤0.01%
+18,001
New +$28K
VIVO
8572
VivoPower PLC
VIVO
$146M
$21K ﹤0.01%
+3,530
New +$40.9K
HURA
8573
TuHURA Biosciences
HURA
$149M
$21K ﹤0.01%
3
+1
+50% +$9.7K
BYU
8574
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$21K ﹤0.01%
52
+23
+79% +$14.6K
SCU
8575
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$21K ﹤0.01%
2,242
-2,751
-55% -$33.5K

Similar funds

Ken Griffin's Q4 2018 Portfolio in Review

As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.

  • Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Ken Griffin opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.